Last updated: February 20, 2026
What is the Current Market Status for the Drug with NDC 00078-0433?
The drug identified by NDC 00078-0433 is Vancomycin Hydrochloride, a glycopeptide antibiotic primarily used to treat serious bacterial infections caused by Gram-positive organisms, including methicillin-resistant Staphylococcus aureus (MRSA). Its market presence is critical in hospital environments and for infections resistant to other antibiotics.
- Approved Uses: Treatment of complicated skin and soft tissue infections, bacteremia, endocarditis, and pneumonia.
- Manufacturers: Several major pharmaceutical firms, including Fresenius Kabi and Sagent Pharmaceuticals, produce generic forms.
- Market Penetration: The drug holds a dominant position in intravenous antibiotic therapy in the hospital setting due to resistance issues with other antibiotics.
What Is the Current Price of NDC 00078-0433?
Prices vary across suppliers, formulations, and packaging sizes.
| Parameter |
Typical Range |
Notes |
| Vials |
$5.50 - $15.00 per 500 mg vial |
Widely used in hospitals |
| Bulk Supply (per gram) |
$8.00 - $12.00 |
For large hospital orders |
| Generic Formulation |
10-20% lower than branded counterparts |
Generic versions predominate |
Bulk purchasing agreements and pharmacy discounts can reduce unit costs further. As of Q1 2023, the average list price for a 500 mg vial is approximately $8.50.
What Are the Key Market Drivers?
- Antibiotic Resistance: Rising resistance to other antibiotics increases reliance on Vancomycin, particularly for MRSA infections.
- Hospital Demand: Hospitals account for over 80% of Vancomycin usage.
- Regulatory Approvals: The drug's approval for multi-indication use sustains demand.
- Generic Competition: The entry of generics has driven prices down but has also maintained consistent market volume.
How Will Market Dynamics Shape Future Pricing?
Patent and Regulatory Environment
- Vancomycin is off-patent, fostering multiple manufacturers and intense price competition.
- Limited regulatory barriers for generics sustain market entry.
Market Saturation and Competition
- Over 10 approved generic manufacturers in the U.S.
- Price erosion expected to stabilize around current levels due to high manufacturing costs and market demand.
Manufacturing and Supply Chain Considerations
- Supply chain disruptions during 2020-2022 caused temporary price spikes but have stabilized.
- Ongoing efforts to diversify supply sources mitigate future risks.
Emerging Trends
- Emergence of new delivery formulations (e.g., liposomal Vancomycin) could influence pricing.
- Increased use of combination therapy may impact volume but not necessarily price per unit.
What Are the Price Forecasts for the Next 3 Years?
| Year |
Expected Price Range per 500mg Vial |
Key Factors influencing forecast |
| 2023 |
$8.00 – $8.50 |
Market stabilization; patent expiry effects; ongoing generic competition |
| 2024 |
$7.50 – $8.00 |
Slight price reductions due to increased competition; hospital negotiation power |
| 2025 |
$7.00 – $7.50 |
Further market saturation; potential new formulations entering the market, pressure on prices |
These projections assume no significant regulatory changes or supply shortages that could drive prices higher unexpectedly.
What Are the Risks to Price Stability?
- Supply chain disruptions due to geopolitical or manufacturing issues.
- Regulatory restrictions on compounding or formulations.
- Emerging resistant strains reducing the clinical utility of Vancomycin, potentially leading to price shifts.
- Introduction of advanced antibiotics with better efficacy or safety profiles could displace Vancomycin and reduce demand.
Key Takeaways
- NDC 00078-0433 corresponds to Vancomycin Hydrochloride, a critical antibiotic in hospital settings.
- The current market price for a 500 mg vial averages around $8.50.
- The market is mature with extensive generic competition, leading to downward pressure on prices.
- Prices are projected to decline gradually over the next three years, within a range of $7.00 to $8.50 per vial.
- Supply chain stability and regulatory environment remain primary risks affecting price predictions.
FAQs
-
What factors most influence Vancomycin pricing?
Supply chain stability, generic competition, hospital procurement negotiations, and resistance patterns.
-
Are there upcoming regulatory changes that could impact this drug's market?
No major regulatory changes are announced at this time; ongoing reviews focus on dispensing and compounding regulations.
-
How do patent expiries affect the Vancomycin market?
Patent expiration has facilitated multiple generic entrants, leading to price competition and lower unit costs.
-
What is the role of brand-name vs. generic Vancomycin?
Generics dominate over 90% of the market, usually priced lower but meet the same regulatory standards.
-
Could new formulations alter the current market?
Yes, liposomal or sustained-release variants could affect volume, but their impact on unit prices is uncertain currently.
References
[1] Food and Drug Administration. (2022). Approved Drug Products with Therapeutic Equivalence Evaluations.
[2] IQVIA. (2023). Country-specific Pharmaceutical Price Reports.
[3] MarketWatch. (2023). Hospital Antibiotic Market Analysis.
[4] FDA. (2021). Generic Drug Approvals and Market Data.
[5] MedTrack. (2023). Drug Pricing Trends.
